These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22202156)

  • 21. Feasibility study on the use of 3D silicon microdosimeter detectors for microdosimetric analysis in boron neutron capture therapy.
    Hu N; Uchida R; Tran LT; Rosenfeld A; Sakurai Y
    Appl Radiat Isot; 2018 Oct; 140():109-114. PubMed ID: 30015038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225.
    Castillo Seoane D; de Saint-Hubert M; Crabbe M; Struelens L; Koole M
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):265-277. PubMed ID: 32441067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
    Morgenstern A; Bruchertseifer F; Apostolidis C
    Curr Radiopharm; 2012 Jul; 5(3):221-7. PubMed ID: 22642390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with
    Kratochwil C; Bruchertseifer F; Rathke H; Bronzel M; Apostolidis C; Weichert W; Haberkorn U; Giesel FL; Morgenstern A
    J Nucl Med; 2017 Oct; 58(10):1624-1631. PubMed ID: 28408529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathways: targeted α-particle radiation therapy.
    Baidoo KE; Yong K; Brechbiel MW
    Clin Cancer Res; 2013 Feb; 19(3):530-7. PubMed ID: 23230321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.
    ; Parker C; Lewington V; Shore N; Kratochwil C; Levy M; Lindén O; Noordzij W; Park J; Saad F
    JAMA Oncol; 2018 Dec; 4(12):1765-1772. PubMed ID: 30326033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.
    Dekempeneer Y; Keyaerts M; Krasniqi A; Puttemans J; Muyldermans S; Lahoutte T; D'huyvetter M; Devoogdt N
    Expert Opin Biol Ther; 2016 Aug; 16(8):1035-47. PubMed ID: 27145158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo calculations of the cellular S-values for α-particle-emitting radionuclides incorporated into the nuclei of cancer cells of the MDA-MB231, MCF7 and PC3 lines.
    Rojas-Calderón EL; Ávila O; Ferro-Flores G
    Appl Radiat Isot; 2018 May; 135():1-6. PubMed ID: 29353192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets.
    Dant JT; Richardson RB; Nie LH
    Phys Med Biol; 2013 May; 58(10):3301-19. PubMed ID: 23615276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy.
    Descalle MA; Hartmann Siantar CL; Dauffy L; Nigg DW; Wemple CA; Yuan A; DeNardo GL
    Cancer Biother Radiopharm; 2003 Feb; 18(1):71-9. PubMed ID: 12667310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-specific alpha-particle dosimetry.
    Palm S; Elgqvist J; Jacobsson L
    Curr Radiopharm; 2011 Oct; 4(4):329-35. PubMed ID: 22202155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
    Allen BJ
    Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Alpha-Particle Therapy for Hematologic Malignancies.
    Jurcic JG
    Semin Nucl Med; 2020 Mar; 50(2):152-161. PubMed ID: 32172800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of solid tumors by alpha emitters released from (224)Ra-loaded sources-internal dosimetry analysis.
    Arazi L; Cooks T; Schmidt M; Keisari Y; Kelson I
    Phys Med Biol; 2010 Feb; 55(4):1203-18. PubMed ID: 20124656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetry and microdosimetry of targeted radiotherapy.
    Bardiès M; Pihet P
    Curr Pharm Des; 2000 Sep; 6(14):1469-502. PubMed ID: 10903404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential and pitfalls of therapy with alpha-particles.
    Welch MJ
    J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
    [No Abstract]   [Full Text] [Related]  

  • 37. Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy.
    Botta F; Mairani A; Battistoni G; Cremonesi M; Di Dia A; Fassò A; Ferrari A; Ferrari M; Paganelli G; Pedroli G; Valente M
    Med Phys; 2011 Jul; 38(7):3944-54. PubMed ID: 21858991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radionuclide antibody-conjugates, a targeted therapy towards cancer.
    Kitson SL; Cuccurullo V; Moody TS; Mansi L
    Curr Radiopharm; 2013 Jun; 6(2):57-71. PubMed ID: 23808764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astatine-211 imaging by a Compton camera for targeted radiotherapy.
    Nagao Y; Yamaguchi M; Watanabe S; Ishioka NS; Kawachi N; Watabe H
    Appl Radiat Isot; 2018 Sep; 139():238-243. PubMed ID: 29864741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
    Allen BJ; Raja C; Rizvi S; Song EY; Graham P
    Phys Med Biol; 2007 Jul; 52(13):L15-9. PubMed ID: 17664565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.